SCYNEXIS, Inc. Interest Expense, Related Party
SCYNEXIS, Inc. (SCYX) reported Interest Expense, Related Party of $0 for the 12-month period ending 2014-12-31, per its 8-K filed 2015-10-30.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseRelatedParty · last filed 2015-10-30
- SCYNEXIS, Inc. interest expense, related party for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
- SCYNEXIS, Inc. interest expense, related party for the quarter ending 2014-09-30 was $0.00, a 100.00% decline year-over-year.
- SCYNEXIS, Inc. interest expense, related party for the quarter ending 2014-06-30 was $0.00, a 100.00% decline year-over-year.
- SCYNEXIS, Inc. interest expense, related party for the quarter ending 2013-12-31 was $189.00K.
| Period end | Interest Expense, Related Party 3 month | Interest Expense, Related Party 6 month | Interest Expense, Related Party 9 month | Interest Expense, Related Party 12 month |
|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2015-10-30 | $0.00 derived: sum of 2 quarters · filed 2015-10-30 | $0.00 derived: sum of 3 quarters · filed 2015-10-30 | $0.00 8-K · filed 2015-10-30 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-13 | $0.00 derived: sum of 2 quarters · filed 2014-11-13 | $0.00 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-13 | $0.00 10-Q · filed 2014-08-13 | ||
| 2013-12-31 | $189.00K derived: 8-K 12 month − 10-Q 9 month · filed 2015-10-30 | $438.00K derived: sum of 2 quarters · filed 2015-10-30 | $666.00K derived: sum of 3 quarters · filed 2015-10-30 | $892.00K 8-K · filed 2015-10-30 |
| 2013-09-30 | $249.00K 10-Q · filed 2014-11-13 | $477.00K derived: sum of 2 quarters · filed 2014-11-13 | $703.00K 10-Q · filed 2014-11-13 | |
| 2013-06-30 | $228.00K 10-Q · filed 2014-08-13 | $454.00K 10-Q · filed 2014-08-13 | ||
| 2013-03-31 | $226.00K 10-Q/A · filed 2014-07-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |